Position in PGEN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$28,608,458
+$10,754,489 QoQ
Shares Held
5,019,028
+8.8% QoQ
Ownership
1.40%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 210 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. PGEN ranks #113 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in PGEN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,608,458 | 5,019,028 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $17,853,969 | 4,613,429 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $18,651,485 | 4,462,078 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $12,662,347 | 3,848,738 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $5,323,838 | 3,749,182 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $5,184,606 | 3,479,602 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,695,832 | 3,299,851 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $3,084,181 | 3,246,508 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $4,892,751 | 3,096,679 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $4,394,783 | 3,030,885 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $4,048,537 | 3,021,297 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,133,982 | 2,911,255 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,307,618 | 2,876,190 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,795,925 | 2,637,666 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,875,405 | 1,891,714 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,963,068 | 1,869,372 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,307,040 | 1,721,672 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $3,647,261 | 1,728,560 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $6,520,963 | 1,757,672 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $7,815,767 | 1,566,286 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $11,901,836 | 1,825,435 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $10,270,640 | 1,490,659 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $11,835,457 | 1,160,339 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $3,645,222 | 1,041,492 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $5,649,682 | 1,132,201 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $3,965,667 | 1,166,373 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||